Injectable magnesium oxychloride cement foam (mocf)-derived scaffold for treating osteoporotic bone defects
US-2024108785-A1 · Apr 4, 2024 · US
US9808555B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9808555-B2 |
| Application number | US-201615065084-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 9, 2016 |
| Priority date | Apr 24, 2013 |
| Publication date | Nov 7, 2017 |
| Grant date | Nov 7, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Bone tissue biomimetic materials, biomimetic constructs that can be formed with the materials, and methods for forming the materials and constructs are described. The bone tissue biomimetic materials include electrospun nanofibers formed of polymers that are conjugated with peptides that include acidic amino acid residues. The materials can incorporate high levels of mineralization so as to provide mechanical strength and promote osteogenesis and/or osteoconductivity on/in the bone tissue biomimetic materials. The materials and constructs can be utilized in forming tissue engineered structures for in vitro and in vivo use. Macroscopic bone tissue biomimetic scaffolds formed from the materials can be seeded with osteogenic cells and utilized to develop bone graft materials that can exhibit strength and osteoconductivity similar to the native bone and that exhibit uniform distribution of nutrients in the scaffolds.
Opening claim text (preview).
What is claimed is: 1. A method for forming a bone tissue biomimetic material comprising: electrospinning a first solution to form a first fibrous sheet including nanofibers, the first solution including a biocompatible polymer conjugated to a peptide, the peptide comprising multiple acidic amino acid residues; and incubating the first fibrous sheet in a simulated body fluid that includes calcium ions, phosphate ions, and an organic acid, calcium phosphate crystals nucleating on the nanofibers of the first fibrous sheet during the incubation. 2. The method of claim 1 , wherein the peptide is derived from a bone extracellular matrix protein. 3. The method of claim 1 , wherein the acidic amino acid residues comprise glutamic acid or aspartic acid. 4. The method of claim 1 , the method further comprising: electrospinning a third solution to form a second fibrous sheet including nanofibers; locating the second fibrous sheet on a surface of the first fibrous sheet following the nucleation of the calcium phosphate crystals and thus forming a multi-layer fibrous sheet; and incubating the multi-layer fibrous sheet in a fourth solution comprising calcium ions, phosphate ions, and an organic acid, calcium phosphate crystals nucleating on the multi-layer fibrous sheet during the incubation. 5. The method of claim 4 , further comprising repeating the electrospinning and incubation steps to add additional layers to the multi-layer fibrous sheet. 6. The method of claim 1 , the first solution further including a second biocompatible polymer. 7. The method of claim 1 , the peptide including from 2 to 10 acidic amino acid residues. 8. The method of claim 1 , wherein the biocompatible polymer is conjugated to the peptide via a cysteine residue of the peptide. 9. A method for forming a bone tissue biomimetic structure comprising: wrapping the first fibrous sheet of claim 1 around a mold following the step of incubating the first fibrous sheet in the simulated body fluid, the mold having a circular cross section and an axial length, the first fibrous sheet being wrapped around the mold such that it encircles the mold and extends along at least a portion of the axial length of the mold with a tubular shape; heat treating the first fibrous sheet; and removing the mold from the first fibrous sheet, the first fibrous sheet retaining the tubular shape following the removal of the mold. 10. The method of claim 9 , further comprising perforating the first fibrous sheet either prior to or following wrapping the first fibrous sheet around the mold. 11. The method of claim 9 , further comprising wrapping the first fibrous sheet around the mold multiple times to form a multi-layered tubular shape, the layers of the multi-layered tubular shape fusing to one another upon the heat treatment. 12. The method of claim 9 , further comprising fusing a plurality of the tubular-shaped first fibrous sheets by application of heat or pressure to the plurality to form a multi-tubular construct.
Biocompatible, e.g. biopolymers or bioelastomers · CPC title
PGA, i.e. polyglycolic acid or polyglycolide · CPC title
Physical properties · CPC title
Sheets, plates, blanks or films · CPC title
Solution · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.